Form 4: Elanco Executive David S. Kinard Reports Changes in Beneficial Ownership

Elanco Animal Health's Executive Vice President, David S. Kinard, reports acquisition and disposal of common stock.

Summary

• On February 27, 2024, David S. Kinard, an Executive Vice President at Elanco Animal Health Inc., reported changes in his beneficial ownership of the company's common stock.
• He acquired 14,562 shares of common stock at $0 and disposed of 6,625 shares at $16.46.
• Following these transactions, Kinard directly owns 139,781 shares of Elanco common stock.
• The acquisition of 14,562 shares was likely related to stock awards or compensation.
• The disposal of 6,625 shares was likely to cover tax obligations.

Sentiment

Score: 5

Explanation: Neutral sentiment as the document primarily reports transactions without indicating a clear positive or negative outlook.

Positives

• The acquisition of shares, even if partially offset by disposals, can be seen as a positive sign of an executive's confidence in the company.

Negatives

• The disposal of shares, while potentially for tax purposes, could be interpreted negatively if it represents a lack of confidence in the company's future performance.

Risks

• Executive stock transactions are always subject to interpretation and could be driven by factors unrelated to the company's performance.

Industry Context

Executive stock transactions are a common occurrence in publicly traded companies and are often related to compensation packages and personal financial planning.

Stakeholder Impact

• The transactions could have a minor impact on shareholder sentiment, depending on how they interpret the executive's actions.

Key Dates